BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23065990)

  • 1. The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
    Buster EH; Baak BC; Bakker CM; Beuers UH; Brouwer JT; Drenth JP; van Erpecum KJ; van Hoek B; Honkoop P; Kerbert-Dreteler MJ; Koek GH; van Nieuwkerk KM; van Soest H; van der Spek BW; Tan AC; Vrolijk JM; Janssen HL
    Neth J Med; 2012 Oct; 70(8):381-5. PubMed ID: 23065990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of hepatitis B infection: a brief review.
    Quan DJ
    Nephrol Nurs J; 2008; 35(5):507-10, 534. PubMed ID: 18856082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.
    Giles M; Visvanathan K; Sasadeusz J
    Antivir Ther; 2011; 16(5):621-8. PubMed ID: 21817183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological agents for the treatment of chronic hepatitis B].
    Sánchez-Tapias JM
    Gastroenterol Hepatol; 2008 Mar; 31(3):120-8. PubMed ID: 18341843
    [No Abstract]   [Full Text] [Related]  

  • 5. [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].
    Lin Q; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):722-5. PubMed ID: 19874684
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current treatment of hepatitis B infection: where do the new nucleos(t)ide analogues fit in?].
    Fuentes Olmo J; Uribarrena Amézaga R
    Gastroenterol Hepatol; 2011; 34(7):492-503. PubMed ID: 21550145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy.
    Gerlich WH
    Intervirology; 2014; 57(3-4):202-11. PubMed ID: 25034489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue therapy for lamivudine-resistant chronic hepatitis B: when and how?
    Liaw YF
    Hepatology; 2007 Feb; 45(2):266-8. PubMed ID: 17256763
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interdisciplinary aspects of and new drugs for chronic hepatitis B].
    Horváth G
    Orv Hetil; 2013 Jul; 154(29):1142-50. PubMed ID: 23853347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.
    Colle I; Adler M; Brenard R; Henrion J; Langlet P; Michielsen P; Orlent H; Reynaert H; Sprengers D; Stärkel P; Van Damme P; Verslype C; Delwaide J;
    Acta Gastroenterol Belg; 2007; 70(4):389-420. PubMed ID: 18330099
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical management of patients with chronic hepatitis B virus infection].
    Rodríguez M; González-Diéguez ML
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():56-65. PubMed ID: 19100232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs.
    Petersen J; Buti M
    Expert Rev Gastroenterol Hepatol; 2012 Dec; 6(6):683-93; quiz 694. PubMed ID: 23237254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus with primary resistance to adefovir.
    Chang TT; Lai CL
    N Engl J Med; 2006 Jul; 355(3):322-3; author reply 323. PubMed ID: 16855278
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B in HIV-infected patients in 2007.
    Garcia-Gasco P; Sheldon J; Soriano V
    J HIV Ther; 2007 Mar; 12(1):19-23. PubMed ID: 17589392
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
    Benhamou Y
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice.
    Lampertico P
    J Hepatol; 2009 Apr; 50(4):644-7. PubMed ID: 19231017
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinical study of adding on adefovir dipivoxil to treat for lamivudine resistant patients with chronic hepatitis B].
    DING JG; SUN QF; FU RQ; WU YH; HONG L
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):387-8. PubMed ID: 19497209
    [No Abstract]   [Full Text] [Related]  

  • 19. [Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil].
    Xing J; Han T; Liu L; Li Y; Li J; Li Y; Xiao SX
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):828-32. PubMed ID: 22433304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future.
    Férir G; Kaptein S; Neyts J; De Clercq E
    Rev Med Virol; 2008; 18(1):19-34. PubMed ID: 17966115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.